prikaz prve stranice dokumenta The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
  Preuzmi
PDF 298.6 KB
Znanstveni rad - Pregledni rad
The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
Biomedicines, 11 (2023), 11; 3096. https://doi.org/10.3390/biomedicines11113096
Paklar, Nataša; Mijić, Maja; Filipec-Kanižaj, Tajana

Institucijski repozitorij: Dr Med - digitalni repozitorij Medicinskog fakulteta Sveučilišta u Zagrebu

Citirajte ovaj rad

Paklar, N., Mijić, M. i Filipec Kanižaj, T. (2023). The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. Biomedicines, 11. (11). doi: 10.3390/biomedicines11113096

Paklar, Nataša, et al. "The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients." Biomedicines, vol. 11, br. 11, 2023. https://doi.org/10.3390/biomedicines11113096

Paklar, Nataša, Maja Mijić i Tajana Filipec Kanižaj. "The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients." Biomedicines 11, br. 11 (2023). https://doi.org/10.3390/biomedicines11113096

Paklar, N., Mijić, M. i Filipec Kanižaj, T. (2023) 'The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients', Biomedicines, 11(11). doi: 10.3390/biomedicines11113096

Paklar N, Mijić M, Filipec Kanižaj T. The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients. Biomedicines [Internet]. 20.11.2023. [pristupljeno 13.05.2024.];11(11). doi: 10.3390/biomedicines11113096

N. Paklar, M. Mijić i T. Filipec Kanižaj, "The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients", Biomedicines, vol. 11, br. 11, Studeni 2023. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:655015. [Citirano: 13.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:655015
Podaci o radu
Naslov (engleski)The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
AutorNataša Paklar
AutorMaja Mijić
AutorTajana Filipec-Kanižaj
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
The increasing prevalence of diabetes mellitus, obesity, and metabolic syndrome in the population can lead to metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD). In Western industrialized countries, this has become a major problem with significant socioeconomic impacts. MASH is now a leading cause of liver transplantation (LT), especially in developed countries. However, the post-transplant outcomes of such patients are a major concern, and published data are limited and extremely variable. In this article, we discuss graft and patient survival after LT, complications, the recurrence of MASH, and MASH appearing de novo after transplantation. Recent studies suggest that patients with MASH have slightly worse short-term survival, potentially due to increased cardiovascular mortality. However, most studies found that longer-term outcomes for patients undergoing LT for MASH are similar or even better than those for other indications. Hepatocellular carcinoma due to MASH cirrhosis also has similar or even better outcomes after LT than other etiologies. In conclusion, we suggest questions and topics that require further research to enhance healthcare for this growing patient population.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaBiomedicines
Brojčani podacivol. 11, br. 11, 3096
e-ISSN2227-9059
DOIhttps://doi.org/10.3390/biomedicines11113096
URN:NBNurn:nbn:hr:105:655015
Datum objave publikacije2023-11-20
URL dokumentahttps://www.mdpi.com/2227-9059/11/11/3096
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Dijeli pod istim uvjetima 4.0 međunarodna (CC BY-SA 4.0)
Datum i vrijeme pohrane2024-04-12 09:19:33